logo
The ‘super powerful' tool behind a pharmaceutical giant's global regulatory operation

The ‘super powerful' tool behind a pharmaceutical giant's global regulatory operation

Yahoo31-01-2025
Rahman Ahrar is a project management office director with a challenge on his hands. His role at the pharmaceutical company GSK is to run the project management office for initiatives that improve the delivery of regulatory applications for new treatments. This means facing the challenge of coordinating multiple innovation projects at once.
Keeping track of all these projects and ensuring that teams can post updates on their progress, share data and keep managers apprised of developments is a key task for Ahrar.
His office has deployed a variety of workflow software to help coordinate this wide range of projects, and cloud-based Smartsheet software has played a significant role in seamlessly managing many initiatives.
'Smartsheet has been instrumental in the past few years for my various teams thanks to its robust and flexible capabilities,' says Ahrar.
The software has helped GSK's processes by introducing greater efficiency, transparency and accountability. 'As a result, we have experienced improved coordination among teams, reduced administrative burdens, and enhanced overall project performance,' he says.
Smartsheet's project management toolkit offers comprehensive dashboards, real-time updates and automated workflows, and these 'significantly enhance our ability to deliver projects', says Ahrar.
This is important work. Improving the delivery of regulatory data is an area of significant research for pharmaceutical companies as they strive to bring new medical treatments to market.
'Regulatory operations are a backbone of pharmaceutical companies,' says Ahrar. 'As PMO director, my role is to create a project management office that will manage all these types of regulatory innovation projects,' he says.
Ahrar finds that Smartsheet's wide range of functions makes it an adaptable and scalable solution for his innovation teams as they look for improved ways to present regulatory data.
Particularly impressive are the system's premium applications such as Dynamic View, which allows users to share information with others while maintaining confidentiality. Another key app is Control Center, a project and portfolio management tool that helps users to create consistent projects.
Meanwhile, the premium Smartsheet app data Shuttle allows data to be exported to other databases such as the customer relationship marketing system or the enterprise resource planning (ERP) database. 'If you look at Smartsheet's whole range of capabilities, these make it super powerful compared with competitors,' he says. 'And from a user's perspective, it is very simple to learn. It's not complicated and is very easy to navigate.'
A good example of Smartsheet's versatility was its role in a budget management tool that Ahrar helped build for GSK Consumer, now Haleon. The tool provides the marketing, procurement and finance teams with a way to plan, budget and track expenditure. The tool integrates finance data from the ERP software, which connects the core processes of a business, with Smartsheet to gain a single budget oversight. 'It allows detailed tracking of expenditures, budget allocations and financial forecasts ensuring that we maintain control over our financial resources and support informed decision-making,' says Ahrar.
A powerful feature of Smartsheet is the ability to manage projects with multiple users and external stakeholders, which speeds up communications and builds a single source of truth. For instance, the Smartsheet update request function allows managers to grant temporary access to specific rows and columns for external parties who are not even Smartsheet users. Allowing external parties to update fields helps simplify the process of gathering information while maintaining control over the system.
One project at GSK involved working collaboratively with four external consultancies alongside the internal GSK team. It was a quick turnaround project over 18 weeks that was high profile, high cost and had to be delivered during the pandemic. Smartsheet's ease of use made it simple to convince the four consultancies and the internal team to use the system to work together easily.
Some of the existing digital platforms used by the regulatory operations teams lack certain key features, such as smart notifications, automation or planning. These are essential for smooth working.
Related: Fewer meetings, greater collaboration: how a project management tool helped a crane builder reach new heights
Ahrar has integrated advanced Smartsheet features such as notifications and data visualisations into these platforms. 'These integrations have significantly enhanced our ability to manage tasks and deadlines efficiently, so all team members are informed about critical updates and actions. This has improved coordination, reduced delays, and has created a more streamlined process,' he says.
GSK is developing new treatments in areas such as HIV, oncology and infectious diseases, and improving the delivery of regulatory data is a vital part of getting those treatments to the people who need them.
'Smartsheet has a variety of capabilities for integration, data visualisation and automation and it offers a simple user experience and easy-to-use interface,' says Ahrar. 'Those features make Smartsheet a strong option for us.'
Read more about how Smartsheet empowers customers around the world to make tangible impacts
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tech Moves: Smartsheet adds to C-suite; Gradial and Zeno Power name senior leadership
Tech Moves: Smartsheet adds to C-suite; Gradial and Zeno Power name senior leadership

Geek Wire

time3 days ago

  • Geek Wire

Tech Moves: Smartsheet adds to C-suite; Gradial and Zeno Power name senior leadership

Tech Moves covers notable hires, promotions and personnel changes in the Pacific NW tech community. Submissions: tips@ Stephanie Berner. (LinkedIn Photo) — Smartsheet's leadership shakeup continues with the appointment of Stephanie Berner as its new chief customer officer. Berner comes to the Bellevue, Wash.-based enterprise software giant from Atlassian, where she served as senior vice president. Berner has also held leadership roles in customer success at LinkedIn, Box and elsewhere. Last week Smartsheet disclosed that long-time CEO Mark Mader is leaving his post while Sunny Gupta steps in as acting CEO. The company also recently named named Tony Giannino as director of security and compliance. '[Berner's] experience in the work management market, proven track record and deep understanding of the B2B SaaS customer journey will be key as we enter a new era of AI-driven innovation,' Gupta said in a statement. — Gradial, a Seattle startup using AI agents to help marketing operations teams increase productivity, has added three new members to its senior leadership: Vikas Kamran joins as president. Kamran was founder and CEO of Revel for nearly 14 years. Infogain acquired Revel in 2020 and Kamran transitioned to chief digital officer for the company. joins as president. Kamran was founder and CEO of Revel for nearly 14 years. Infogain acquired Revel in 2020 and Kamran transitioned to chief digital officer for the company. Richard Rocca is vice president of sales and comes to the role from Adobe, where he worked for more than a decade. is vice president of sales and comes to the role from Adobe, where he worked for more than a decade. Chelsea Halliday is now head of marketing. Halliday has held marketing leadership roles for companies including Zillow Group, Vercel and MongoDB. A.C. Charania. (LinkedIn Photo) — Zeno Power, a Seattle startup developing nuclear-powered batteries, hired A.C. Charania as senior vice president of space business development. The company, which is co-located in Washington, D.C., announced $50 million of new funding in May. Charania was most recently chief technologist at NASA and has 25 years of experience in aerospace innovation in the public and private sectors. At Zeno Power, Charania will lead the company's pursuit of deals with NASA, the U.S. Department of Defense and commercial companies. Charania was also with Jeff Bezos' Blue Origin, leaving the role of lunar campaign director. — Longtime Seattle-area investor Brianna McDonald has joined the board of directors at the Angel Capital Association. This spring, McDonald became CEO of a new organization called Ecosystem Venture Group, which blends startup investment funds with services for entrepreneurs and investors. Phil Levin. (UW Photo) — Phil Levin is stepping in as interim director of the University of Washington's EarthLab, an institute that spans multiple colleges and departments. Levin is a conservation scientist, professor in the UW's College of the Environment, and lead scientist for The Nature Conservancy of Washington. '[T]he challenges we face are enormous. Climate change, biodiversity loss, environmental injustice — none of these have quick fixes. But I've never believed our job is to be optimistic. Our job is to be honest, brave, and imaginative,' Levin said in announcing his new role. Levin succeeds Ben Packard, who served as the inaugural Harriet Bullitt Endowed executive director of EarthLab beginning in 2017. Packard had previous leadership roles at The Nature Conservancy and Starbucks. — Lauren Olson, former director of fund management at the Seattle-based investment firm Breakwater Ventures, is now the fund operations manager at betaworks in New York. Betaworks this summer announced the close of a $66 million fund to invest in pre-seed and seed state startups. Olson previously worked for the SeaChange Fund and Madrona Venture Group. — Will Daughterty, president and CEO of Seattle's Pacific Science Center, joined the board of trustees for PCC Community Markets (PCC). The long-time retail grocery cooperative has also hired Amy Chow as the co-op's new chief financial officer. Chow was previously with the high-end kitchen and cookware store Sur La Table.

Eli Lilly and GSK drive South Korea's drug licensing activity
Eli Lilly and GSK drive South Korea's drug licensing activity

Yahoo

time3 days ago

  • Yahoo

Eli Lilly and GSK drive South Korea's drug licensing activity

China's growth as a drug licensing hub is well-treaded, but a surge in deals in South Korea means it is also becoming a go-to destination for big pharma companies, according to market analysis. According to the GlobalData deal database, the deal value for South Korean drug licensing agreements has so far reached $7.68bn this year, marking a 113% increase from 2024. The out-licensing of South Korean drugs to international firms surged by 180%, around a $5.1bn increase, from 2024 to so far in 2025. The momentum in out-licensing was largely fuelled by billion-dollar agreements among large pharma companies such as Eli Lilly and GSK. Eli Lilly outlaid $630m for OliX Pharmaceuticals' metabolic-associated steatohepatitis (MASH) candidate in February and agreed a separate $1.3bn deal for biotech Rznomics' RNA-based gene therapies in May. GSK meanwhile licensed ABL Bios' blood-brain barrier shuttle platform for $2.8bn in April. GlobalData senior business fundamentals analyst Ophelia Chan says: 'Once primarily recognised for generic drug production, South Korea is now transitioning into a global hub for novel innovative drug discovery and advanced drug technologies, bolstered by government support and increasing international investment. This transition positions the country as a strategic bridge between Western and Asian markets.' In January 2025, South Korea established the National Bio Committee to make the country one of five global leaders in the bio industry by 2035. Part of this mandate is to enhance the country's competitiveness in novel drug and advanced biopharmaceutical technology development. According to South Korea's Ministry of Science and IT, the committee plans to create a Won1tn ($695.7m) fund to promote private investment in the biopharmaceutical and vaccine industry. The initiative builds on ongoing reforms as the government aims to reduce drug development timelines and costs, GlobalData said. South Korea joins China as a fast-growing destination for promising pipeline drug candidates. The total deal value of US licensing of innovator drug candidates from Chinese biopharma companies has surged 280% since 2020. A bipartisan report in the US has called for at least $15bn of funding over the next five years to avoid being eclipsed by China in biotech advancement. The future of the US and European pharma industries' relationship with Chinese and South Korean companies will require sturdy trade relationships between the regions. This has been stretched this year with tariffs imposed by President Donald Trump as his administration looks to bolster domestic manufacturing in the US. While licensing deals do not equate to imported products, Trump has maintained that transferring technology to China poses a threat to national security. The controversial BIOSECURE Act, which would have blacklisted Chinese biotechs and manufacturers from accessing US funding and collaborating with US pharma companies, is still in regulatory limbo. Another announcement made by the US Food and Drug Administration (FDA) was for an immediate review of new clinical trials that involve sending American citizens' living cells to China and other hostile countries for genetic engineering and subsequent infusion back into US patients. This move may potentially impact deals that pharma and biotech's have in place with Chinese contract development and manufacturing organisations (CDMOs). "Eli Lilly and GSK drive South Korea's drug licensing activity" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio

Smartsheet Appoints Stephanie Berner as Chief Customer Officer to Champion Customer Success in New Era of Growth and AI Innovation
Smartsheet Appoints Stephanie Berner as Chief Customer Officer to Champion Customer Success in New Era of Growth and AI Innovation

Yahoo

time4 days ago

  • Yahoo

Smartsheet Appoints Stephanie Berner as Chief Customer Officer to Champion Customer Success in New Era of Growth and AI Innovation

Experienced B2B SaaS leader to implement customer-centric initiatives to drive market leadership BELLEVUE, Wash., August 13, 2025--(BUSINESS WIRE)--Smartsheet, the AI-enhanced enterprise-grade work management platform, today announced the appointment of Stephanie Berner as Chief Customer Officer (CCO). As the company embarks on a new chapter of accelerated growth and innovation, Berner's appointment reinforces the company's commitment to customer satisfaction and underscores the company's vision to deliver exceptional customer experiences at every touchpoint. In this role, Berner will champion a new era of customer success, pioneering innovative strategies that embrace AI to deepen customer relationships and drive sustained value across the entire customer lifecycle. "We're thrilled to welcome Stephanie to the Smartsheet team," said Sunny Gupta, Acting CEO and Executive Chairman of the Board. "Her experience in the work management market, proven track record and deep understanding of the B2B SaaS customer journey will be key as we enter a new era of AI-driven innovation. Stephanie will be an integral leader in our next phase of growth, ensuring we are doing everything possible to make our customers successful." Berner brings over 15 years of distinguished leadership experience from industry B2B innovators, including Atlassian and LinkedIn, where she was crucial in building and scaling high-performing teams. Her proven expertise in navigating global growth, from pre-IPO to international enterprise, positions Smartsheet to enter new markets and redefine customer success as it integrates transformative AI capabilities into its platform. "I am thrilled to join Smartsheet at such an instrumental moment," said Berner. "The company's reputation and success are founded on a passionate and loyal customer base, a cornerstone I'm excited to build upon, and we have an incredible opportunity to leverage Smartsheet's AI-driven innovation to further delight our users and forge new pathways for customer success." As CCO, Berner will be vital in defining and executing a comprehensive customer strategy, ensuring every Smartsheet customer receives unparalleled value and support. Her leadership will be critical in fostering deep customer relationships, maximizing lifetime value, and transforming users into passionate advocates. About Smartsheet Smartsheet is the modern enterprise work management platform trusted by millions of people at companies across the globe, including over 85% of the 2025 Fortune 500 companies. The category pioneer and market leader, Smartsheet delivers powerful solutions fueling performance and driving the next wave of innovation. Visit to learn more. View source version on Contacts Media Contact Lisa Henthornpr@

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store